RxDoctor Payments Data

George Abdelmessieh, DPM

Foot & Ankle Surgery · Tucson, AZNPI 1104232115

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,701 of the $24,594 with a category attached, or 84.2%. Flower Orthopedics Coporation accounts for 91.2% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $6,563 and has fallen 97.6% since, to $155 in 2025.

$24,594in general payments, 2019–2025

Across 61 payments — averaging $403.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Flower Orthopedics Coporation$22K
  • Zimmer Biomet$403
  • Smith+Nephew$272
  • Osiris Therapeutics Inc.$266
  • Organogenesis Inc.$203
  • Metric Medical Devices, Inc.$179
  • plus $836 from 16 others

What the payments were for

  • Consulting fees$20,70184%
  • Travel & lodging$1,3926%
  • Food & beverage$2,50010%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,594 in reported general payments places this provider in the 85th percentile of 291 foot & ankle surgery providers in Arizona.

See all foot & ankle surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$67,946
Medicare patients
163
Services billed
536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip37$1,153
Doxycycline Hyclate45$658
Gabapentin24$284
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim27$195
Ciprofloxacin Hcl16$177
Methylprednisolone13$136
Oxycodone Hcl14$75

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →